ARCHIVES

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

This article is from The Cancer Letter archive.

Vol. 18 No. 35 | September 11, 1992

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP For the Month of January

January 27, 2012

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011

Pesticides Not Linked To High Rates Of Breast Cancer.

May 18, 2001

NCI Has Congressional Mandate Fr Planning Clinical Trials of Unconventional Therapies, Chabner Says

June 5, 1992

Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees

January 6, 1984